AGM Report

Synairgen (SYN) AGM Report 2019

AGM Date: June 3, 2019

Report Author: Tim Grattan

The Synairgen 2019 AGM was held on Monday 2nd June at the offices of Fladgate LLP, 16 Great Queen Street, London. For anyone who is unfamiliar with the company, Synairgen is an AIM listed UK based biotech company focused primarily on developing new treatments for Asthma, COPD and other respiratory diseases. The company floated on AIM in November 2004, issuing approximately 8m shares at 130p/share valuing the company at around £28m. There have been several placings since the IPO; the most recent was in Sept 2018 to raise £2.9 million through the issue of around 18M ordinary Shares at a price of 16p/share (a discount of around 11%). The shares currently trade at around 13p/share valuing Synairgen at about £14m. The company broker Finncap currently have a price target of

...

Not a member? Join today

Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:

Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities

Join now